The estimated Net Worth of Marcus Schulz is at least $2 Million dollars as of 25 August 2023. Mr. Schulz owns over 347 units of Biolife Solutions Inc stock worth over $976,229 and over the last 4 years he sold BLFS stock worth over $1,023,371. In addition, he makes $0 as Vice President und Global Sales at Biolife Solutions Inc.
Sign up
Mr. Schulz BLFS stock SEC Form 4 insiders trading
Marcus has made over 39 trades of the Biolife Solutions Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently he sold 347 units of BLFS stock worth $3,814 on 25 August 2023.
The largest trade he's ever made was selling 4,919 units of Biolife Solutions Inc stock on 26 July 2021 worth over $224,552. On average, Marcus trades about 767 units every 27 days since 2020. As of 25 August 2023 he still owns at least 42,097 units of Biolife Solutions Inc stock.
You can see the complete history of Mr. Schulz stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Marcus Schulz biography
Marcus Schulz serves as Vice President, Global Sales of the Company. He joined the Company in August 2019 as Vice President of Sales, evo® Platform. In that role, Mr. Schulz supported the Company’s partnerships with specialty couriers that market the evo cold chain management platform to the regenerative medicine market. Prior to joining the Company, Mr. Schulz served in a variety of strategic business development and executive sales leadership roles with companies including Siemens Healthcare (2000-2009, most recently as Director, Strategic National Accounts), Johnson & Johnson (2010-2012, most recently as Sales Director), Aramark Healthcare Technologies (2012-2013, most recently as Director of Business Development), Abbott Laboratories (2013-2015, most recently as Executive Director, Healthcare Improvement), Belimed, AG (2015-2016, most recently as Executive Director, Strategic Solutions Group) and most recently, GE Healthcare (2016-2019, most recently as General Manager, National Accounts), where he managed a $1 billion annual revenue strategic account.
How old is Marcus Schulz?
Marcus Schulz is 42, he's been the Vice President und Global Sales of Biolife Solutions Inc since 2020. There are 15 older and 2 younger executives at Biolife Solutions Inc. The oldest executive at Biolife Solutions Inc is Thomas Girschweiler, 61, who is the Director.
What's Marcus Schulz's mailing address?
Marcus's mailing address filed with the SEC is 3303 MONTE VILLA PARKWAY, SUITE 310, BOTHELL, WA, 98021.
Insiders trading at Biolife Solutions Inc
Over the last 21 years, insiders at Biolife Solutions Inc have traded over $156,215,880 worth of Biolife Solutions Inc stock and bought 12,236,637 units worth $91,960,074 . The most active insiders traders include Partners Master Fund, L.P.C..., Thomas Girschweiler und Walter Villiger. On average, Biolife Solutions Inc executives and independent directors trade stock every 13 days with the average trade being worth of $1,018,157. The most recent stock trade was executed by Sarah Aebersold on 1 July 2024, trading 3,000 units of BLFS stock currently worth $63,090.
What does Biolife Solutions Inc do?
bothell, wa-based biolife solutions, inc. (nasdaq: blfs), is a leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud hosted biologistics cold chain management app for smart shippers.
What does Biolife Solutions Inc's logo look like?
Complete history of Mr. Schulz stock trades at Biolife Solutions Inc
Biolife Solutions Inc executives and stock owners
Biolife Solutions Inc executives and other stock owners filed with the SEC include:
-
Michael Rice,
President, Chief Executive Officer, Director -
Aby Mathew,
Executive Vice President and Chief Scientific Officer -
Roderick de Greef,
Chief Financial Officer, Chief Operating Officer, Secretary, IR Contact Officer -
Michael P. Rice,
Chairman & CEO -
Dr. Aby J. Mathew,
Chairman of Scientific Advisory Board, Exec. VP & Chief Scientific Officer -
Roderick de Greef,
Pres & COO -
Karen Foster,
Chief Quality Officer -
Troy Wichterman,
Chief Financial Officer -
Todd Berard,
Chief Marketing Officer -
Raymond Cohen,
Independent Chairman of the Board -
Joseph Schick,
Independent Director -
Andrew Hinson,
Independent Director -
Thomas Girschweiler,
Director -
Karen Foster,
Chief Quality Officer -
Marcus Schulz,
Vice President, Global Sales -
Todd Berard,
Chief Marketing Officer -
Marcus Schulz,
Chief Revenue Officer -
Sarah Aebersold J.D.,
VP of Global HR -
Frederick Stewart,
Director -
Thomas Girschweiler,
Director -
Joe Annicchiarico,
Chief Operating Officer -
Daphne Taylor,
Chief Financial Officer -
Matt Snyder,
Vice President -
Walterwavi Holding Ag Villiger,
-
Partners Master Fund, L.P.C...,
-
Geraint Phillips,
SVP, Global Operations -
Timothy L. Moore,
Director -
Amy Du Ross,
Director -
Rachel Ellingson,
Director -
Walter Villiger,
10% owner -
John G Ph D Baust,
Director -
Howard S Breslow,
Director -
Alan F Rich,
Vice President -
Buskirk Robert Van,
Director -
James Mathers,
Chief Revenue Officer -
Dusty Tenney,
COO and President -
Joydeep Goswami,
Director -
Troy Wichterman,
Chief Financial Officer -
Sarah Aebersold,
Chief Human Resources Officer -
Garrie Richardson,
Chief Revenue Officer